OpenAI Expands Enterprise Reach with Acquisition of Multi’s Video Collaboration Platform

OpenAI continues its strategic expansion into enterprise solutions with the acquisition of Multi, a startup known for its innovative video-first collaboration platform. This move comes shortly after OpenAI’s acquisition of database tech firm Rockset, signaling a robust M&A strategy aimed at bolstering its capabilities in corporate software solutions. Multi, previously known as Remotion, gained traction…

Read More
jamie-siminoff_source_INC.com

DOOR to Acquire HelloTech, Launching Comprehensive DOOR Services Nationwide

Latch, Inc., rebranding as DOOR, has announced its acquisition of HelloTech, Inc., a leading provider of on-demand, in-home technology support services. This strategic move marks the official launch of DOOR Services, leveraging HelloTech’s robust platform alongside technology obtained through Latch’s previous acquisition of Honest Day’s Work (HDW). DOOR Services will introduce a full suite of…

Read More
CEO Greg Loos and Co-founder Linda Miller

TrackLight Secures $3M Seed Funding to Revolutionize Fraud Prevention with AI-Powered Platform; Unveils AI Co-Pilot Ray the Parrot

TrackLight, a trailblazer in AI-driven fraud detection and prevention, has launched its innovative platform aimed at combatting fraud across government and corporate sectors. The company also announced a significant milestone with a $3 million Seed funding round led by BarronKent and Growth Factory. This investment is set to accelerate TrackLight’s platform development, sales initiatives, and…

Read More

EpilepsyGTx Secures $10M to Advance Breakthrough Gene Therapy for Focal Refractory Epilepsy

EpilepsyGTx, a pioneering biotechnology firm specializing in advanced gene therapies for focal refractory epilepsy, has announced a successful $10 million seed funding round. The financing, spearheaded by the UCL Technology Fund and bolstered by Health Technology Holding, marks a significant milestone in the company’s journey towards combating this challenging neurological disorder. Led by CEO Nicolas…

Read More

Wilya Secures $4 Million Seed Funding to Transform HR SaaS for Manufacturing and Supply Chain Efficiency

Wilya, previously known as Gig and Take, has announced a significant milestone with the closure of a $4 million seed funding round led by Ironspring Ventures. This funding underscores Wilya’s innovative approach in revolutionizing HR practices within the manufacturing and supply chain sectors through its advanced SaaS platform. Founder and CEO Rahil Siddiqui expressed excitement…

Read More

RXO to Acquire Coyote Logistics from UPS, Cementing Position as a Leader in North American Transportation

In a strategic move to bolster its presence in the North American transportation sector, RXO (NYSE: RXO) has announced its definitive agreement to acquire Coyote Logistics from UPS for $1.025 billion in cash. This acquisition is set to propel RXO to the forefront as the third-largest provider of brokered transportation in the region, significantly enhancing…

Read More

Vico Therapeutics Secures €65.8 Million in Series B Funding to Advance Groundbreaking Neurological Therapies

Vico Therapeutics, a pioneering clinical-stage genetic medicines company, has successfully closed its Series B funding round with a total investment of €65.8 million ($70.7 million). This financing round, led by Seroba and Kurma Partners, marks a significant milestone in Vico’s journey towards developing transformative therapies for severe neurological diseases. Vico Therapeutics specializes in antisense oligonucleotide…

Read More

VoltR Secures €4 Million to Revolutionize Battery Sustainability in Europe

VoltR Advances Sustainable Lithium Battery Manufacturing with €4 Million Seed Funding VoltR, a pioneering French deep-tech company specializing in sustainable lithium batteries, has successfully raised €4 million in seed funding to scale its innovative processes. The funding round, led by prominent investors including C4 Ventures, Exergon, Pays de la Loire Participations, and Anjou Amorçage, marks…

Read More

Valneva’s Breakthrough: Canada Approves World’s First Chikungunya Vaccine

Valneva SE has achieved a historic milestone with Health Canada’s approval of the world’s first chikungunya vaccine. Following its successful launch in the U.S. and pending European authorization, this decision underscores IXCHIQ®’s pivotal role in global healthcare strategy. Chikungunya, a mosquito-borne virus causing severe joint pain and fever, poses a significant public health threat with…

Read More

Ethris GmbH: Leading the Charge in mRNA-Based Therapeutics with $5 Million Investment

Since its inception, Ethris GmbH has been a trailblazer in mRNA technology, revolutionizing the biotech landscape with its innovative approach to respiratory and cardiovascular diseases. Founded on a vision of harnessing messenger RNA (mRNA) for therapeutic breakthroughs, Ethris has consistently pushed boundaries, drawing attention from investors and global biotech leaders alike. Breakthroughs and Strategic Growth…

Read More